CClinicalTrials.gg
Status unknownNCT05330949Updated Apr 15, 2022

Optical Coherence Tomography Angiography Compared to Maternal Doppler in Screening for Hypertension in Pregnancy

An observational study in Pregnancy Induced Hypertension, sponsored by Minia University. Status unknown at 1 site in Egypt. Open to female participants aged 22 Years to 45 Years. Per ClinicalTrials.gov, last updated 2022-04-15.

Sponsored by Minia University · Observational

The sponsor has not verified this record recently (last verified Apr 2022), so the status shown — last known as Recruiting — may be out of date.
Study type
Observational
Model
Case-control
Time perspective
Prospective
Enrollment
60
Ages
22 Years to 45 Years
Sex
Female
01

Study summary

Pregnancy related hypertension is one of the most prevalent obstetric complications. The aim of the study is to evaluate the validity and sensitivity of OCT angiography in prediction of pregnancy induced hypertensive disorders in comparison to maternal doppler in the first and second trimesters of pregnancy

02

Conditions studied

  • Pregnancy Induced Hypertension
03

In context

Hypertension, Pregnancy-Induced

240 studies on the registry are indexed under Hypertension, Pregnancy-Induced; 66 are open to participants now.

This study's planned enrollment of 60 is below the median of 225 across 68 observational studies indexed under Hypertension, Pregnancy-Induced.

Browse Hypertension, Pregnancy-Induced studies →

Lead sponsor

Minia University is the lead sponsor of 356 studies on the registry; 115 are open to participants now.

Of its 6 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
22 Years to 45 Years
Sexes eligible
Female
Sampling method
Probability sample

Study population

two groups according to the risk of developing hypertension during pregnancy

Inclusion criteria

  • Pregnant women in the first and second trimesters

Exclusion criteria

Exclusion Criteria:

  • pregnant females with associated systemic vascular disease as diabetes, SLE
05

Study design

Observational model
Case-control
Time perspective
Prospective
Enrollment
60 participants (estimated)
Patient registry
No

Groups and cohorts

  • case group

    Diagnostic Test: Optical coherence Tomography Angiography, Uterine artry doppler

  • control

    Diagnostic Test: Optical coherence Tomography Angiography, Uterine artry doppler

Interventions

  • Diagnostic testOptical coherence Tomography Angiography, Uterine artry doppler

    vascular changes in retina by OCT angiography and uterine artry doppler in the first and second trimesters

06

What researchers measure

Primary outcomes

  1. validity and sensitivity of OCT angiography

    sensitivity of OCTA in comparison to doppler in prediction of pregnancy related hypertension

    Time frame: 6 months

07

Study locations

1 of 1 sites recruiting
  • Minia University
    Minya, Minia Governorate 61111, Egypt
    • Mohamed EK Esmail, MD · Contact · mohamed.ismaeel@mu.edu.eg · 00201006185533
    • Mohamed EK Esmail, MD · Principal investigator
    • Kareem Shaheen, MD · Sub investigator
    • Heba R AttaAllah, MD · Principal investigator
    Recruiting
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 15, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05330949
Lead sponsor
Minia University
Responsible party
Mohamed Esmail Khalil Esmail (lecturer of Ophthalmology, Minia University) — Principal investigator
First posted
Apr 15, 2022
Start date
Apr 1, 2022
Primary completion
Dec 2022 (estimated)
Completion
Dec 2022 (estimated)
Last update
Apr 15, 2022

Study contacts

Mohamed EK Esmail, MD
Contact
mohamed.ismaeel@mu.edu.eg
00201006185533
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Apr 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion